RETAVASE® (reteplase) is a recombinant plasminogen activator which catalyzes the cleavage of endogenous plasminogen to generate plasmin. Plasmin degrades the fibrin matrix of the thrombus, exerting its thrombolytic action.

Contact us

If you would like to learn more about RETAVASE® (reteplase), get updates when they become available, or have one of our National Account Managers (NAMs) contact you, please fill out the fields below.


Terms and Conditions

By checking this box, you are giving Chiesi USA, Inc. permission to send or contact you with the information you have requested, as well as information and updates on RETAVASE or other Chiesi products in the future. Chiesi USA, Inc. will not sell or share any of your information with third parties.



Medical Information

To request specific medical information about RETAVASE or to report adverse events or product complaints, contact the Medical Information Department.

Adverse events may also be reported to the FDA’s MedWatch Program at 1-800-FDA-1088.

Mail:
Chiesi USA, Inc.
175 Regency Woods Place
Suite 600
Cary, NC 27518
Email:
US.Medical@chiesi.com
Phone:
1-888-661-9260
Fax:
1-866-443-3092

Contact Chiesi USA, Inc.


Mail:
Chiesi USA, Inc.
175 Regency Woods Place
Suite 600
Cary, NC 27518
Phone:
1-888-466-6505